UNC Project Malawi, Lilongwe, Malawi.
UNC-CH School of Medicine, Chapel Hill, North Carolina, USA.
Transfus Med. 2023 Oct;33(5):355-371. doi: 10.1111/tme.12988. Epub 2023 Aug 28.
Blood and blood products are listed as one of the essential medicines by the World Health Organization (WHO). In addition to inadequate supply, most sub-Saharan Africa (SSA) nations fail to meet their blood needs because many donated blood units are discarded because they are contaminated with transfusion-transmitted infections (TTIs). We sought to estimate the prevalence of TTIs, identify the risk factors for TTIs among blood donors, and identify the efforts and interventions that have been made to improve blood safety in Southern African nations, particularly the nations of the South African Development Community (SADC). We investigated the prevalence and risk factors for TTIs, blood safety interventions, and blood quality improvement in the SADC region from major PubMed/MEDLINE, Cochrane Library, and HINARI databases from 1 January 2011 to 31 April 2021. All investigations followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). In meta-analysis, we estimated the pooled TTIs prevalence and summarised the same using forest plots. A total of 180 articles published from the SSA region were identified covering our three targeted themes: TTI prevalence, risk factors for TTIs, and blood safety improvements. Of these 180 articles, only 27 (15%) focused on the SADC region. The overall pooled TTI prevalence estimate was 2.0% (95% CI: 1.0-3.0) and hepatitis B was the most prevalent TTI in the region (prevalence = 3.0; 95% CI: 2.0-5.0). The prevalence of HIV, HCV, and syphilis was 2.0% (95% CI: 1.0-4.0), 1.0% (95% CI: 0.0-2.0), and 2.0% (95% CI: 0.0-8.0), respectively. In general, replacement donors and first-time donors were more likely to be infected with TTIs than repeat donors. Twelve articles explored blood safety research in the region; however, they vary greatly highlighting the need for consistent and more comprehensive research. Few publications were identified that were from the SADC region, indicating lack of research or resources towards improving both quantity and quality of blood donation. TTI prevalence remains one of the highest in the world and blood safety recommendations vary across the region. More effort should be directed towards developing a cohesive regional blood transfusion policy and effective blood monitoring and evaluation strategies.
血液和血液制品被世界卫生组织(WHO)列为基本药物之一。除了供应不足外,大多数撒哈拉以南非洲(SSA)国家无法满足其血液需求,因为许多捐献的血液因被输血传播感染(TTI)污染而被丢弃。我们试图估计 TTI 的流行率,确定献血者中 TTI 的危险因素,并确定为提高南部非洲国家,特别是南部非洲发展共同体(SADC)国家的血液安全性而采取的努力和干预措施。我们从主要的 PubMed/MEDLINE、Cochrane 图书馆和 HINARI 数据库调查了 2011 年 1 月 1 日至 2021 年 4 月 31 日期间 SADC 地区 TTI 的流行率和危险因素、血液安全干预措施以及血液质量改善情况。所有调查均遵循系统评价和荟萃分析的首选报告项目(PRISMA)。在荟萃分析中,我们使用森林图估计了 TTI 总体流行率并对其进行了总结。从 SSA 地区共确定了 180 篇发表的文章,涵盖了我们的三个目标主题:TTI 流行率、TTI 的危险因素以及血液安全的改善。在这 180 篇文章中,只有 27 篇(15%)关注 SADC 地区。总的 TTI 总体流行率估计为 2.0%(95%CI:1.0-3.0),乙型肝炎是该地区最常见的 TTI(流行率=3.0;95%CI:2.0-5.0)。HIV、HCV 和梅毒的流行率分别为 2.0%(95%CI:1.0-4.0)、1.0%(95%CI:0.0-2.0)和 2.0%(95%CI:0.0-8.0)。一般来说,替代供体和首次供体比重复供体更有可能感染 TTI。有 12 篇文章探讨了该地区的血液安全研究;然而,它们差异很大,突出表明需要进行一致和更全面的研究。从 SADC 地区确定的出版物很少,表明缺乏研究或资源来提高献血的数量和质量。TTI 的流行率仍然是世界上最高的之一,血液安全建议在该地区各不相同。应该更加努力制定有凝聚力的区域输血政策和有效的血液监测和评估策略。